10/02/2026
๐๐ซ๐ ๐ฐ๐ ๐ฌ๐๐๐ซ๐ข๐ง๐ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐๐ฐ๐๐ฒ ๐๐ซ๐จ๐ฆ ๐๐๐ซ๐ ๐ญ๐ก๐๐ฒ ๐๐จ๐ฎ๐ฅ๐ ๐ฌ๐๐๐๐ฅ๐ฒ ๐๐๐ง๐๐๐ข๐ญ ๐๐ซ๐จ๐ฆ?
In this video, Seemal Desai, MD, FAAD, rethinks the safety perceptions around JAK inhibitors in vitiligoโexplaining where the black box warning came from, why it doesnโt map neatly onto most vitiligo patients, and how modern monitoring has transformed the safety picture.
His case: Keep risk communication proportionate and grounded, not reflexively alarmist.
๐๐๐ญ๐๐ก ๐๐จ๐ฐ: https://hubs.li/Q04y3Vzt0